Literature DB >> 15359535

Apolipoprotein E polymorphism and its association with serum lipid levels in Brazilian children.

Everaldo De França1, João Guilherme Bezerra Alves, Mara H Hutz.   

Abstract

The influence of apolipoprotein E (APOE) genotypes on plasma lipid levels was determined in 414 Brazilian healthy children of mixed ethnicity, age 5 to 15 years (mean 8.9+/-2.9). The APOE*3 allele was the most frequent (77%), followed by APOE*4 (17%) and APOE*2 (6%). The pattern of lipid differences among genotypes was similar in both boys and girls. We did not detect an increase in cholesterol levels with the presence of the APOE*4 allele. Because a growing body of evidence suggests that the effect of *4 depends on its interaction with diet, the frequency of *4 might be more variable in children than in adults as well as among populations. Children carrying a *2 allele had lower total cholesterol (TC) and LDL-cholesterol levels (138.47+/-24.32 and 77.72+/-19.42, respectively) compared with *3/*3 children (158.33+/-25.28 and 97.05+/-21.82, respectively). Mean TC/HDLC ratio was also lower in children with the APOE*2 allele (3.27+/-0.66 versus 3.64+/-0.76). In this highly admixed population sample, the *2 anti-atherogenic lipid pattern is already detected in children.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15359535

Source DB:  PubMed          Journal:  Hum Biol        ISSN: 0018-7143            Impact factor:   0.553


  9 in total

1.  Apolipoprotein A5-1131T>C polymorphism, but not APOE genotypes, increases susceptibility for dyslipidemia in children and adolescents.

Authors:  D D V Brito; A P Fernandes; K B Gomes; F F Coelho; N G Cruz; A P Sabino; J E Cardoso; P P Figueiredo-Filho; R Diamante; C R Norton; M O Sousa
Journal:  Mol Biol Rep       Date:  2010-12-04       Impact factor: 2.316

2.  APOE polymorphism is associated with lipid profile, but not with arterial stiffness in the general population.

Authors:  Rafael O Alvim; Silvia R S Freitas; Noely E Ferreira; Paulo C J L Santos; Roberto S Cunha; José G Mill; José E Krieger; Alexandre C Pereira
Journal:  Lipids Health Dis       Date:  2010-11-08       Impact factor: 3.876

3.  Genetic influences on blood lipids and cardiovascular disease risk: tools for primary prevention.

Authors:  José M Ordovas
Journal:  Am J Clin Nutr       Date:  2009-04-01       Impact factor: 7.045

4.  Several different lactase persistence associated alleles and high diversity of the lactase gene in the admixed Brazilian population.

Authors:  Deise C Friedrich; Sidney E B Santos; Ândrea K C Ribeiro-dos-Santos; Mara H Hutz
Journal:  PLoS One       Date:  2012-09-28       Impact factor: 3.240

5.  Relationship between lipid and hematological profiles with adiposity in obese adolescents.

Authors:  Lisianny Camilla Cocri do Nascimento Ferreira; Humberto José Gomes da Silva; Tatiana Acioli Lins; Wagner Luiz do Prado
Journal:  Rev Bras Hematol Hemoter       Date:  2013

6.  Relative variations of gut microbiota in disordered cholesterol metabolism caused by high-cholesterol diet and host genetics.

Authors:  Tao Bo; Shanshan Shao; Dongming Wu; Shaona Niu; Jiajun Zhao; Ling Gao
Journal:  Microbiologyopen       Date:  2017-06-28       Impact factor: 3.139

7.  Analysis of apolipoprotein E genetic polymorphism in a large ethnic Hakka population in southern China.

Authors:  Zhixiong Zhong; Heming Wu; Hesen Wu; Pingsen Zhao
Journal:  Genet Mol Biol       Date:  2018-11-29       Impact factor: 1.771

8.  In the Heart of the Amazon: Noncommunicable Diseases and Apolipoprotein E4 Genotype in the Riverine Population.

Authors:  Gabriela P F Arrifano; Jacqueline I Alvarez-Leite; José Rogério Souza-Monteiro; Marcus Augusto-Oliveira; Ricardo Paraense; Barbarella M Macchi; André Pinto; Reinaldo B Oriá; José Luiz Martins do Nascimento; Maria Elena Crespo-Lopez
Journal:  Int J Environ Res Public Health       Date:  2018-09-07       Impact factor: 3.390

Review 9.  Th17/Treg Imbalance and Atherosclerosis.

Authors:  Xin He; Bo Liang; Ning Gu
Journal:  Dis Markers       Date:  2020-10-31       Impact factor: 3.434

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.